Jordi Barquinero Mañez I am an MD, specialized in Internal Medicine, and senior researcher at the Vall d'Hebron Research Institute (VHIR). Doctor from the UAB with Extraordinary Award. I received post-doctoral training at the Fred Hutchinson Cancer Research Center (Seattle). I am currently leading the Gene and Cell Therapy group at the VHIR. My interest has focused on understanding disease mechanisms and finding effective therapies for orphan diseases. In our laboratory we have worked on gene therapy research projects for several rare diseases, mainly of genetic origin. Institutions of which they are part Head of group Gene and Cell Therapy Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Jordi Barquinero Mañez LinkedIn Twitter Orcid Email Institutions of which they are part Head of group Gene and Cell Therapy Vall Hebron Institut de Recerca I am an MD, specialized in Internal Medicine, and senior researcher at the Vall d'Hebron Research Institute (VHIR). Doctor from the UAB with Extraordinary Award. I received post-doctoral training at the Fred Hutchinson Cancer Research Center (Seattle). I am currently leading the Gene and Cell Therapy group at the VHIR. My interest has focused on understanding disease mechanisms and finding effective therapies for orphan diseases. In our laboratory we have worked on gene therapy research projects for several rare diseases, mainly of genetic origin.
I am an MD specialized in Internal Medicine (Vall d'Hebron University Hospital). I worked at the Intensive Care Unit (HUVH) and the Emergency Department of the Hospital de l'Esperança. I did pre-doctoral studies on autoimmunity at the University of Louisville (Dr. N. Harris) and got my PhD at the Autonomous University of Barcelona with Extraordinary Award, with a work that contributed to the description of a new disease, the primary antiphospholipid syndrome. I was a postdoc at the Fred Hutchinson Cancer Research Center (Dr. R. Storb, Seattle), where I was trained in hematopoietic stem cell gene therapy. I am currently group leader of the gene and cell therapy group (VHIR), where we investigate new therapeutic strategies for rare genetic diseases, mostly in collaboration with other groups on campus and from other national and international institutions. We have participated in research projects using models of multiple sclerosis, hemophilia, MNGIE, in a clinical trial for Fanconi anemia type A (coordinated by Drs. J. Bueren and P. Río, at the CIEMAT (Madrid)), and more recently, in a novel gene therapy approach for muscular dystrophy due to merosin deficiency, in collaboration with the Pediatric Neurology group (Drs. F. Munell and D. Gómez). Our group is part of the national network TERAV (RICORS). I have participated in European projects (INHERINET, CONSERT), including one as coordinator (HEMO-IPS, e-Rare-2), in which we experimentally demonstrated the mutagenic mechanism of the "Royal disease", the form of hemophilia B that affected several European royal families in the 19th and 20th centuries. I participate as a teacher in different master's degrees and I am a member of the American and European Gene and Cell Therapy Societies, and was one of the founding members of the Spanish Society of Gene and Cell Therapy.
Research lines Gene therapy of congenital muscular dystrophy due to merosin deficiency Development of a new gene therapy strategy based on high-capacity adenoviral vectors, which we carry out in collaboration with the group of Dr. Rubén Hernández, from the University of Navarra. IP: Jordi Barquinero Mañez Projects Teràpia gènica en MDC1A IP: Jordi Barquinero Mañez Collaborators: Laia Perez Lasarte, Maria Pallares Masmitja Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 67400 Reference: JDC2022-049508-I Duration: 01/01/2024 - 31/12/2025 Activitat del pèptid K18-8R com a potenciador de la transducció IP: Jordi Barquinero Mañez Collaborators: - Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 20000 Reference: 2021 LLAV 00032 Duration: 12/10/2022 - 11/07/2023 Distrofia muscular congénita tipo 1A: inhibición de la fibrosis y corrección mediante edición génica IP: Jordi Barquinero Mañez Collaborators: Laura Costa Comellas, Francina Munell Casadesus, David Gómez Andrés, Rocío Piñera Moreno, Maria Pallares Masmitja Funding agency: Instituto de Salud Carlos III Funding: 117370 Reference: PI22/01027 Duration: 01/01/2023 - 31/12/2025 Fisiologia i fisiopatologia digestiva IP: Chaysavanh Manichanh Collaborators: Itxarone Izaskun Bilbao Aguirre, Zaida Soler Luque, Jordi Barquinero Mañez, Oscar Segarra Canton, Gerard Serrano Gomez, Cristina Dopazo Taboada, Rocío Piñera Moreno Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 40000 Reference: 2021 SGR 00459 Duration: 01/01/2022 - 30/06/2025 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 … Next page › Last page »
